| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/24/2005 | CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 08/24/2005 | CN1658866A Tri-substituted heteroaryls and methods of making and using the same |
| 08/24/2005 | CN1658863A Severe sepsis preventive therapeutic agent |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658859A Therapeutic agent for overactive bladder |
| 08/24/2005 | CN1658851A Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 08/24/2005 | CN1657094A Chinese medicinal capsule for treating nephropathy and its production method |
| 08/24/2005 | CN1657091A Chinese medicinal composition for treating uroschesis and stranguria and its preparation method |
| 08/24/2005 | CN1657060A Shenkang freeze-dried powder injection for injection and its preparation technology |
| 08/24/2005 | CN1657059A Shenkeshu capsule for treating chronic renal failure and its preparation technology |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1215865C Traditional Chinese medicine for tonifying kidney |
| 08/23/2005 | US6933387 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles |
| 08/23/2005 | US6933386 Process for preparing certain pyrrolotriazine compounds |
| 08/23/2005 | US6933321 For therapy of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/23/2005 | CA2370888C Renin inhibitors |
| 08/23/2005 | CA2218714C Dosage form comprising oxybutynin |
| 08/23/2005 | CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 08/18/2005 | WO2005075416A1 Amorphous tamsulosin hydrochloride |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | WO2005074907A1 Gene expression controlling agent |
| 08/18/2005 | WO2005074896A1 Sustained release preparation |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182130 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 08/18/2005 | US20050182093 Novel compounds |
| 08/18/2005 | US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents |
| 08/18/2005 | US20050182045 Fused ring 4-oxopyrimidine derivative |
| 08/18/2005 | US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders |
| 08/18/2005 | US20050181031 Permeation enhancer comprising fatty acid ester and/or a terpene; urogenital and respiratory system disorders |
| 08/18/2005 | CA2558877A1 Solifenacin succinate-containing composition |
| 08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
| 08/18/2005 | CA2554262A1 Sustained-release preparations |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562573A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 08/17/2005 | EP1463725B1 Process and intermediates for pyridazinone antidiabetic agents |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1200446B1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 08/17/2005 | EP1122253B1 Quinazolinone derivatives |
| 08/17/2005 | EP1087943B1 Therapeutic biaryl derivatives |
| 08/17/2005 | EP1073723B1 Ste20-related protein kinases |
| 08/17/2005 | CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 08/17/2005 | CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 08/17/2005 | CN1656098A Fused bicyclic pyrimidine derivatives |
| 08/17/2005 | CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs |
| 08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656089A Phenyl-thiophene type vitamin D receptor modulators |
| 08/17/2005 | CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 08/17/2005 | CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655788A 1H-imidazo[4, 5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1654066A Kidney-nourishing yang-strengthening medicine |
| 08/17/2005 | CN1654061A Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat nephrotic syndrome |
| 08/17/2005 | CN1654060A 'Kidney-Benefiting' glucose injection and its preparing process |
| 08/17/2005 | CN1654059A Application of 'Kidney Benefiting Injection' in the process for preparing medicine to treat diabetic nephropathy |
| 08/17/2005 | CN1654058A Medicine for treating chronic kidney failure and its preparing process |
| 08/17/2005 | CN1654053A Chinese medicinal tonifying wine with kidney tonifying, qi sooting, kidney invigorating, blood benefiting, kidney nourishing, essence benefiting functions |
| 08/17/2005 | CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin |
| 08/17/2005 | CN1215045C Stable salts of novel derivatives of 3, 3-diphenylpropylamines |
| 08/17/2005 | CN1214805C Medicine of treating nephrotic syndrome |
| 08/17/2005 | CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 08/17/2005 | CN1214790C Method for preparing isoxazole substituted composition for treating inflammation |
| 08/17/2005 | CN1214788C Compositions for treatment and prevention of cardiovascular diseases |
| 08/16/2005 | US6930188 Stable hydrate of a muscarinic receptor antagonist |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | CA2098533C Carrier system against gnrh |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176698 Neuropeptide Y antagonists |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176685 Administering bisphosphonate compounds such as ibandronate, minodronate, pamidronate, risedronate, zoledronate, and alendronate; osteoporosis |
| 08/11/2005 | US20050176635 Remedy for bone mtabolic diseases |
| 08/11/2005 | US20050176123 Protease inhibitor |